{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:15:59Z","timestamp":1779916559756,"version":"3.53.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Param Hansa Philanthropies"},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2020-5255\/GENOMIC\/ADHOC\/BMS"],"award-info":[{"award-number":["2020-5255\/GENOMIC\/ADHOC\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/006509"],"award-info":[{"award-number":["CRG\/2019\/006509"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"DOI":"10.1186\/s13072-025-00646-x","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:05:01Z","timestamp":1765613101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP\/TAZ signaling mediated activation of partial or full EMT states to colon tumours"],"prefix":"10.1186","volume":"19","author":[{"given":"Harsha","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemadri","family":"Subhadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit Kumar","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"1","key":"646_CR1","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1038\/s41598-021-87486-3","volume":"11","author":"CS Lee","year":"2021","unstructured":"Lee CS, et al. Enhancing the landscape of colorectal cancer using targeted deep sequencing. Sci Rep. 2021;11(1):8154. https:\/\/doi.org\/10.1038\/s41598-021-87486-3.","journal-title":"Sci Rep"},{"issue":"17","key":"646_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E36550","volume":"10","author":"Z Su","year":"2024","unstructured":"Su Z, El Hage M, Linnebacher M. Mutation patterns in colorectal cancer and their relationship with prognosis. Heliyon. 2024;10(17):e36550. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E36550.","journal-title":"Heliyon"},{"issue":"1","key":"646_CR3","doi-asserted-by":"publisher","DOI":"10.3892\/IJMM.2024.5448","volume":"55","author":"ML Tornesello","year":"2025","unstructured":"Tornesello ML. TP53 mutations in cancer: molecular features and therapeutic opportunities (review). Int J Mol Med. 2025;55(1):7. https:\/\/doi.org\/10.3892\/IJMM.2024.5448.","journal-title":"Int J Mol Med"},{"issue":"1","key":"646_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-39608-2","volume":"13","author":"M Sinkala","year":"2023","unstructured":"Sinkala M. Mutational landscape of cancer-driver genes across human cancers. Sci Rep. 2023;13(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-023-39608-2.","journal-title":"Sci Rep"},{"issue":"1","key":"646_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/NG0593-42","volume":"4","author":"D Dittmer","year":"1993","unstructured":"Dittmer D, et al. Gain of function mutations in p53. Nat Genet. 1993;4(1):42\u20136. https:\/\/doi.org\/10.1038\/NG0593-42.","journal-title":"Nat Genet"},{"issue":"1","key":"646_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/NRCLINONC.2017.151","volume":"15","author":"K Sabapathy","year":"2018","unstructured":"Sabapathy K, Lane DP. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others. Nat Rev Clin Oncol. 2018;15(1):13\u201330. https:\/\/doi.org\/10.1038\/NRCLINONC.2017.151.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"646_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/HUMU.23035","volume":"37","author":"L Bouaoun","year":"2016","unstructured":"Bouaoun L, Sonkin D, Ardin M, Hollstein M, Byrnes G, Zavadil J, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37(9):865\u201376. https:\/\/doi.org\/10.1002\/HUMU.23035.","journal-title":"Hum Mutat"},{"issue":"5170","key":"646_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/SCIENCE.8023157","volume":"265","author":"Y Cho","year":"1994","unstructured":"Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumourigenic mutations. Science. 1994;265(5170):346\u201355. https:\/\/doi.org\/10.1126\/SCIENCE.8023157.","journal-title":"Science"},{"issue":"18","key":"646_CR9","doi-asserted-by":"publisher","first-page":"8748","DOI":"10.1093\/NAR\/GKT630","volume":"41","author":"A Eldar","year":"2013","unstructured":"Eldar A, Rozenberg H, Diskin-Posner Y, Rohs R, Shakked Z. Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions. Nucleic Acids Res. 2013;41(18):8748\u201359. https:\/\/doi.org\/10.1093\/NAR\/GKT630.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"646_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-30481-7","volume":"13","author":"O Hassin","year":"2022","unstructured":"Hassin O, et al. Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients. Nat Commun. 2022;13(1):1\u201315. https:\/\/doi.org\/10.1038\/s41467-022-30481-7.","journal-title":"Nat Commun"},{"issue":"1","key":"646_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cdd.2017.180","volume":"25","author":"EH Baugh","year":"2018","unstructured":"Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018;25(1):154\u201360. https:\/\/doi.org\/10.1038\/cdd.2017.180.","journal-title":"Cell Death Differ"},{"issue":"1","key":"646_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/S13046-024-03232-3","volume":"43","author":"S Caporali","year":"2024","unstructured":"Caporali S, et al. Selective metabolic regulations by p53 mutant variants in pancreatic cancer. J Exp Clin Cancer Res. 2024;43(1):310. https:\/\/doi.org\/10.1186\/S13046-024-03232-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"646_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-019-1375-9","volume":"38","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. J Exp Clin Cancer Res. 2019;38(1):1\u201316. https:\/\/doi.org\/10.1186\/S13046-019-1375-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7568","key":"646_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/NATURE15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu J, et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 2015;525(7568):206\u201311. https:\/\/doi.org\/10.1038\/NATURE15251.","journal-title":"Nature"},{"issue":"2","key":"646_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/GR.117523.110","volume":"22","author":"T Hinoue","year":"2012","unstructured":"Hinoue T, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012;22(2):271\u201382. https:\/\/doi.org\/10.1101\/GR.117523.110.","journal-title":"Genome Res"},{"issue":"1","key":"646_CR16","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1073\/PNAS.1216922110","volume":"110","author":"KI Leonova","year":"2013","unstructured":"Leonova KI, et al. p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci U S A. 2013;110(1):E89\u201398. https:\/\/doi.org\/10.1073\/PNAS.1216922110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"646_CR17","first-page":"6579","volume":"63","author":"E Peterson","year":"2003","unstructured":"Peterson E, B\u00f6gler O, Taylor SM. p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. Cancer Res. 2003;63(20):6579\u201382.","journal-title":"Cancer Res"},{"issue":"5","key":"646_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2022.111568","volume":"41","author":"E Panatta","year":"2022","unstructured":"Panatta E, Butera A, Mammarella E, Pitolli C, Mauriello A, Leist M, et al. Metabolic regulation by p53 prevents R-loop-associated genomic instability. Cell Rep. 2022;41(5):111568. https:\/\/doi.org\/10.1016\/J.CELREP.2022.111568.","journal-title":"Cell Rep"},{"issue":"5","key":"646_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/CARCIN\/BGR036","volume":"32","author":"SO Suh","year":"2011","unstructured":"Suh SO, et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis. 2011;32(5):772\u20138. https:\/\/doi.org\/10.1093\/CARCIN\/BGR036.","journal-title":"Carcinogenesis"},{"issue":"9","key":"646_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/JMCB\/MJAA040","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang C, Liu J, Xu D, Zhang T, Hu W, Feng Z. Gain-of-function mutant p53 in cancer progression and therapy. J Mol Cell Biol. 2020;12(9):674\u201387. https:\/\/doi.org\/10.1093\/JMCB\/MJAA040.","journal-title":"J Mol Cell Biol"},{"issue":"21","key":"646_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS232113287","volume":"23","author":"KA Roszkowska","year":"2022","unstructured":"Roszkowska KA, Piecuch A, Sady M, Gajewski Z, Flis S. Gain of function (GOF) mutant p53 in cancer\u2014current therapeutic approaches. Int J Mol Sci. 2022;23(21):13287. https:\/\/doi.org\/10.3390\/IJMS232113287.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"646_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM10111561","volume":"10","author":"D Sinha","year":"2020","unstructured":"Sinha D, Saha P, Samanta A, Bishayee A. Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules. 2020;10(11):1\u201322. https:\/\/doi.org\/10.3390\/BIOM10111561.","journal-title":"Biomolecules"},{"issue":"3","key":"646_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumour progression and metastasis. Trends Cell Biol. 2019;29(3):212\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001.","journal-title":"Trends Cell Biol"},{"issue":"43","key":"646_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/PNAS.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/PNAS.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"646_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.15252\/EMBR.201540488","volume":"17","author":"S Di Agostino","year":"2016","unstructured":"Di Agostino S, Sorrentino G, Ingallina E, Valenti F, Ferraiuolo M, Bicciato S, et al. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins. EMBO Rep. 2016;17(2):188\u2013201. https:\/\/doi.org\/10.15252\/EMBR.201540488.","journal-title":"EMBO Rep"},{"issue":"5","key":"646_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03722-8","volume":"12","author":"L Jin","year":"2021","unstructured":"Jin L, et al. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression. Cell Death Dis. 2021;12(5):1\u201310. https:\/\/doi.org\/10.1038\/s41419-021-03722-8.","journal-title":"Cell Death Dis"},{"issue":"1","key":"646_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/0008-5472.CAN-23-1490","volume":"84","author":"D Wang","year":"2024","unstructured":"Wang D, Nakayama M, Hong CP, Oshima H, Oshima M. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGF\u03b2 Signaling\u2013Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors. Cancer Res. 2024;84(1):56\u201368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1490.","journal-title":"Cancer Res"},{"issue":"7","key":"646_CR28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, et al. Single-cell transcriptomic analysis of primary and metastatic tumour ecosystems in head and neck cancer. Cell. 2017;171(7):1611-1624.e24. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044.","journal-title":"Cell"},{"issue":"11","key":"646_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/NM.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136. https:\/\/doi.org\/10.1038\/NM.3967.","journal-title":"Nat Med"},{"issue":"1","key":"646_CR30","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1186\/S12885-024-13009-8","volume":"24","author":"A Nzitakera","year":"2024","unstructured":"Nzitakera A, et al. TP53 mutation status and consensus molecular subtypes of colorectal cancer in patients from Rwanda. BMC Cancer. 2024;24(1):1266. https:\/\/doi.org\/10.1186\/S12885-024-13009-8.","journal-title":"BMC Cancer"},{"issue":"10","key":"646_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1101\/GAD.299198.117","volume":"31","author":"A Tovy","year":"2017","unstructured":"Tovy A, et al. P53 is essential for DNA methylation homeostasis in na\u00efve embryonic stem cells, and its loss promotes clonal heterogeneity. Genes Dev. 2017;31(10):959\u201372. https:\/\/doi.org\/10.1101\/GAD.299198.117.","journal-title":"Genes Dev"},{"issue":"7","key":"646_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/NG1834","volume":"38","author":"DJ Weisenberger","year":"2006","unstructured":"Weisenberger DJ, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787\u201393. https:\/\/doi.org\/10.1038\/NG1834.","journal-title":"Nat Genet"},{"issue":"3","key":"646_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2353\/JMOLDX.2007.060170","volume":"9","author":"S Ogino","year":"2007","unstructured":"Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn. 2007;9(3):305\u201314. https:\/\/doi.org\/10.2353\/JMOLDX.2007.060170.","journal-title":"J Mol Diagn"},{"issue":"9","key":"646_CR34","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1038\/oncsis.2013.35","volume":"2","author":"D Ahmed","year":"2013","unstructured":"Ahmed D, et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2(9):e71\u2013e71. https:\/\/doi.org\/10.1038\/oncsis.2013.35.","journal-title":"Oncogenesis"},{"issue":"4","key":"646_CR35","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/S11010-020-04036-7","volume":"476","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhou MY, Gu YJ, Chen L, Wang Y. ZEB1: new advances in fibrosis and cancer. Mol Cell Biochem. 2021;476(4):1643\u201350. https:\/\/doi.org\/10.1007\/S11010-020-04036-7.","journal-title":"Mol Cell Biochem"},{"issue":"13","key":"646_CR36","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/1878-0261.13140","volume":"16","author":"YZ Mazzu","year":"2022","unstructured":"Mazzu YZ, Liao YuRou, Nandakumar S, Sj\u00f6str\u00f6m M, Jehane LE, Ghale R, et al. Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity. Mol Oncol. 2022;16(13):2451\u201369. https:\/\/doi.org\/10.1002\/1878-0261.13140.","journal-title":"Mol Oncol"},{"issue":"45","key":"646_CR37","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1073\/PNAS.1318192110","volume":"110","author":"M Lu","year":"2013","unstructured":"Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. Microrna-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A. 2013;110(45):18144\u20139. https:\/\/doi.org\/10.1073\/PNAS.1318192110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"646_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.797261","volume":"12","author":"S Sahoo","year":"2021","unstructured":"Sahoo S, et al. Immunosuppressive traits of the hybrid epithelial\/mesenchymal phenotype. Front Immunol. 2021;12:797261. https:\/\/doi.org\/10.3389\/FIMMU.2021.797261.","journal-title":"Front Immunol"},{"issue":"3","key":"646_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1083\/JCB.201103097","volume":"195","author":"NH Kim","year":"2011","unstructured":"Kim NH, Kim HS, Li X-Y, Lee I, Choi H-S, Kang SE, et al. A p53\/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial\u2013mesenchymal transition. J Cell Biol. 2011;195(3):417\u201333. https:\/\/doi.org\/10.1083\/JCB.201103097.","journal-title":"J Cell Biol"},{"issue":"8","key":"646_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/CAS.12713","volume":"106","author":"M Tamura","year":"2015","unstructured":"Tamura M, Sasaki Y, Kobashi K, Takeda K, Nakagaki T, Idogawa M, et al. CRKL oncogene is downregulated by p53 through miR-200s. Cancer Sci. 2015;106(8):1033\u201340. https:\/\/doi.org\/10.1111\/CAS.12713.","journal-title":"Cancer Sci"},{"issue":"6","key":"646_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/NCB1875","volume":"11","author":"SP Wang","year":"2009","unstructured":"Wang SP, et al. P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol. 2009;11(6):694\u2013704. https:\/\/doi.org\/10.1038\/NCB1875.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"646_CR42","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.15252\/EMBR.201438587","volume":"15","author":"J Kim","year":"2014","unstructured":"Kim J, Bae S, An S, Park JK, Kim EM, Hwang S-G, et al. Cooperative actions of p21 WAF 1 and p53 induce Slug protein degradation and suppress cell invasion. EMBO Rep. 2014;15(10):1062\u20138. https:\/\/doi.org\/10.15252\/EMBR.201438587.","journal-title":"EMBO Rep"},{"issue":"8","key":"646_CR43","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1242\/JCS.061002","volume":"123","author":"L Roger","year":"2010","unstructured":"Roger L, Jullien L, Gire V, Roux P. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010;123(8):1295\u2013305. https:\/\/doi.org\/10.1242\/JCS.061002.","journal-title":"J Cell Sci"},{"issue":"3","key":"646_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PCBI.1005456","volume":"13","author":"B Huang","year":"2017","unstructured":"Huang B, Lu M, Jia D, Ben-Jacob E, Levine H, Onuchic JN. Interrogating the topological robustness of gene regulatory circuits by randomization. PLoS Comput Biol. 2017;13(3):e1005456. https:\/\/doi.org\/10.1371\/JOURNAL.PCBI.1005456.","journal-title":"PLoS Comput Biol"},{"key":"646_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2020.607670","volume":"8","author":"E Alvarado-Ortiz","year":"2021","unstructured":"Alvarado-Ortiz E, de la Cruz-L\u00f3pez KG, Becerril-Rico J, Sarabia-S\u00e1nchez MA, Ortiz-S\u00e1nchez E, Garc\u00eda-Carranc\u00e1 A. Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches. Front Cell Dev Biol. 2021;8:607670. https:\/\/doi.org\/10.3389\/FCELL.2020.607670.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"646_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, et al. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022;13(11):1\u201314. https:\/\/doi.org\/10.1038\/s41419-022-05408-1.","journal-title":"Cell Death Dis"},{"issue":"2","key":"646_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1200\/JCO.21.02014","volume":"40","author":"M Pan","year":"2022","unstructured":"Pan M, et al. TP53 gain-of-function and non-gain-of-function mutations are differentially associated with sidedness-dependent prognosis in metastatic colorectal cancer. J Clin Oncol. 2022;40(2):171\u20139. https:\/\/doi.org\/10.1200\/JCO.21.02014.","journal-title":"J Clin Oncol"},{"issue":"1","key":"646_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/J.CGH.2006.10.006","volume":"5","author":"SH Itzkowitz","year":"2007","unstructured":"Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC III, Sontag S, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007;5(1):111\u20137. https:\/\/doi.org\/10.1016\/J.CGH.2006.10.006.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"646_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS18050961","author":"M Ferraiuolo","year":"2017","unstructured":"Ferraiuolo M, Verduci L, Blandino G, Strano S. Mutant p53 protein and the hippo transducers YAP and TAZ: a critical oncogenic node in human cancers. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/IJMS18050961.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"646_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.CELL.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RYYJ, Jackson RAA, Thiery JPP. EMT: 2016. Cell. 2016;166(1):21\u201345. https:\/\/doi.org\/10.1016\/J.CELL.2016.06.028.","journal-title":"Cell"},{"issue":"29","key":"646_CR51","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41388-023-02749-9","volume":"42","author":"RA Sample","year":"2023","unstructured":"Sample RA, Nogueira MF, Mitra RD, Puram SV. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer. Oncogene. 2023;42(29):2237\u201348. https:\/\/doi.org\/10.1038\/s41388-023-02749-9.","journal-title":"Oncogene"},{"issue":"9","key":"646_CR52","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1073\/PNAS.1914937117","volume":"117","author":"H Jiang","year":"2020","unstructured":"Jiang H, et al. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A. 2020;117(9):4770\u201380. https:\/\/doi.org\/10.1073\/PNAS.1914937117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"646_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.neo.2016.07.007","volume":"18","author":"E Lee","year":"2016","unstructured":"Lee E, et al. DNMT1 regulates epithelial-mesenchymal transition and cancer stem cells, which promotes prostate cancer metastasis. Neoplasia. 2016;18(9):553\u201366. https:\/\/doi.org\/10.1016\/j.neo.2016.07.007.","journal-title":"Neoplasia"},{"key":"646_CR54","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2147\/DDDT.S129305","volume":"11","author":"N Zhang","year":"2017","unstructured":"Zhang N, Liu Y, Wang Y, Zhao M, Tu L, Luo F. Decitabine reverses TGF-\u03b21-induced epithelial\u2013mesenchymal transition in non-small-cell lung cancer by regulating miR-200\/ZEB axis. Drug Des Devel Ther. 2017;11:969\u201383. https:\/\/doi.org\/10.2147\/DDDT.S129305.","journal-title":"Drug Des Devel Ther"},{"key":"646_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS9061540","author":"K Cervena","year":"2020","unstructured":"Cervena K, Siskova A, Buchler T, Vodicka P, Vymetalkova V. Methylation-based therapies for colorectal cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/CELLS9061540.","journal-title":"Cells"},{"issue":"11","key":"646_CR56","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.4161\/15592294.2014.971608","volume":"9","author":"H Cardenas","year":"2014","unstructured":"Cardenas H, et al. TGF-\u03b2 induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells. Epigenetics. 2014;9(11):1461\u201372. https:\/\/doi.org\/10.4161\/15592294.2014.971608.","journal-title":"Epigenetics"},{"issue":"11","key":"646_CR57","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/GR.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/GR.239244.118.","journal-title":"Genome Res"},{"issue":"8","key":"646_CR58","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/NAR\/GKV1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71\u2013e71. https:\/\/doi.org\/10.1093\/NAR\/GKV1507.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"646_CR59","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc. 2009;4(8):1184\u201391. https:\/\/doi.org\/10.1038\/nprot.2009.97.","journal-title":"Nat Protoc"},{"issue":"1","key":"646_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-16747-x","volume":"7","author":"PW Eide","year":"2017","unstructured":"Eide PW, Bruun J, Lothe RA, Sveen A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep. 2017;7(1):1\u20138. https:\/\/doi.org\/10.1038\/s41598-017-16747-x.","journal-title":"Sci Rep"},{"issue":"4","key":"646_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/NMETH.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139. https:\/\/doi.org\/10.1038\/NMETH.1923.","journal-title":"Nat Methods"},{"issue":"9","key":"646_CR62","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/GB-2008-9-9-R137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137. https:\/\/doi.org\/10.1186\/GB-2008-9-9-R137.","journal-title":"Genome Biol"},{"issue":"6","key":"646_CR63","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/BIOINFORMATICS\/BTQ033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841\u20132. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTQ033.","journal-title":"Bioinformatics"},{"issue":"Web Server issu","key":"646_CR64","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/NAR\/GKU365","volume":"42","author":"F Ram\u00edrez","year":"2014","unstructured":"Ram\u00edrez F, D\u00fcndar F, Diehl S, Gr\u00fcning BA, Manke T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014;42(Web Server issue):W187\u201391. https:\/\/doi.org\/10.1093\/NAR\/GKU365.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"646_CR65","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136. https:\/\/doi.org\/10.1038\/nmeth.4463.","journal-title":"Nat Methods"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-025-00646-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-025-00646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:06:45Z","timestamp":1768910805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13072-025-00646-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1186\/s13072-025-00646-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7241016\/v1","asserted-by":"object"}]},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for the publication of this data. There is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}